Valacyclovir
VALTREX, Valacyclovir, Valacyclovir Hydrochloride
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
NADAC/unit
$0.2300
No Shortage
Tier 1: 53.2%
9 Manufacturers
18 ANDAs
Valacyclovir hydrochloride is a deoxynucleoside analogue DNA polymerase inhibitor indicated for: Adult Patients ( 1.1 ) Cold Sores (Herpes Labialis) Genital Herpes Treatment in immunocompetent pati....
vs. brand VALTREX: Generic saves up to 98% per unit
Market Intelligence
2024-05-08 Class III Recall: Viatris Inc
Generic Manufacturers
AUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCGLAXOSMITHKLINEHETERO LABS LTD UNIT VJUBILANT GENERICS LTDMYLAN PHARMACEUTICALS INCRISING PHARMA HOLDINGS INCSUN PHARMACEUTICAL INDUSTRIES LTDYILING PHARMACEUTICAL LTDZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
